CYDY: Another biotech that looks promising.

OTC:CYDY   CytoDyn Inc
Cytodyn Inc. (CYDY) is another biotech. It uses viral immunology to develop treatments for HIV, Covid-19 treatment, and NASH (nonalcoholic steatohepatitis). NASH is greatly on the rise.
The Price action from 2006 to 2020 could be seen as an irregular "W" base. Price has gone the major resistance line (1) now twice on a big upswing in volume . There is a positive reversal the daily RSI . Watch for a up break above the current daily short term downtrend line. The ".2" if a .62 correction of ".1" so the current short term correction may be over. We'll see.
IFFFF this count is correct there is major possible gain ahead.
All small biotechs are volatile and risky. Process your way. Best to ya.